Fluoroquinolone‐Associated Peripheral and Central Nervous System‐Related Disorders: A Large German Claims‐Based Cohort Study

20260 citationsJournal Articlegold Open Access

Authors

Julia Wicherski · Federal Institute for Drugs and Medical Devices

Jonas Peltner · German Center for Neurodegenerative Diseases

Cornelia Becker · Federal Institute for Drugs and Medical Devices

Katrin Schüssel · Wissenschaftliches Institut der AOK

Gabriela Brückner · Wissenschaftliches Institut der AOK

Andreas Schlotmann · Wissenschaftliches Institut der AOK

H. Schröder

Abstract

FQ episodes were associated with an increased risk for neurological and neuropsychiatric events, especially within the first 92 days after initial dispensing. Risk estimates vary by age and gender subgroups.

Topics & Keywords

Antibiotics Pharmacokinetics and Efficacy Blood disorders and treatments Drug-Induced Ocular Toxicity

UN Sustainable Development Goals

Gender equality

Publication Details

Published in: European Journal of Neurology

Volume 33, Issue 4, pp. e70585-e70585

DOI: 10.1111/ene.70585

Field-Weighted Citation Impact: 0.00

Command Palette